Tong Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tong Cheng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Xiaojing Zhang
Department of Clinical Biobank, Affiliated Hospital of Nantong University & Medical School of Nantong University, Jiangsu 226001, China
2 shared publications - Bing Lu
Clinical and Translational Research Center & Institute of Oncology, Affiliated Hospital of Nantong University, Nantong, P.R. China
1 shared publication Bowen Wu
Nantong University Affiliated Hospital: Affiliated Hospital of Nantong University
1 shared publication- Hui Zhang
Department of Clinical Biobank, Affiliated Hospital of Nantong University & Medical School of Nantong University, Jiangsu 226001, China
1 shared publication - Jianfei Huang
Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, P.R. China
1 shared publication Manyu Xu
Nantong University Affiliated Hospital: Affiliated Hospital of Nantong University
1 shared publication
Latest Publications
- RetractedOpen Access
- 19 September 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2694377
[Retracted] KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma
Background. The tumor immune microenvironment (TME) is associated with cancer progression and immune escape. Although KLHDC8A has been reported in glioma in vitro, the expression and clinical significance of this gene in clinical samples are unknown. Methods. The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases were used to evaluate the mRNA expression level of KLHDC8A and its significance in the glioma TME. Tissue microarray‐based multiple immunohistochemical staining was conducted to determine KLHDC8A protein levels and characterize the immune signature of tumor‐infiltrating immune cells in gliomas. Results. Tumor cells and tumor‐associated macrophages expressed KLHDC8A. The expression of KLHDC8A was higher in glioma tissues than in normal brain tissues and was associated with patient clinical characteristics. Gliomas exhibited a high abundance of macrophages, neutrophils, regulatory T cells, and the immune checkpoint PD‐L1, as well as high KLHDC8A expression. Cox regression analysis showed that KLHDC8A+CD68+ macrophages and KLHDC8A predicted unfavorable survival in patients with glioma. Finally, protein‐protein interaction network analysis showed that the KLHDC8A expression was associated with hypoxia and oxidative stress. Conclusions. KLHDC8A is a potential marker for the clinical diagnosis of glioma. The immune characteristics of macrophages play a crucial role in predicting patients with glioma, providing a new avenue for targeted glioma therapy.
- 19 September 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2694377
RetractedOpen Access[Retracted] KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma
Background. The tumor immune microenvironment (TME) is associated with cancer progression and immune escape. Although KLHDC8A has been reported in glioma in vitro, the expression and clinical significance of this gene in clinical samples are unknown. Methods. The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases were used to evaluate the mRNA expression level of KLHDC8A and its significance in the glioma TME. Tissue microarray‐based multiple immunohistochemical staining was conducted to determine KLHDC8A protein levels and characterize the immune signature of tumor‐infiltrating immune cells in gliomas. Results. Tumor cells and tumor‐associated macrophages expressed KLHDC8A. The expression of KLHDC8A was higher in glioma tissues than in normal brain tissues and was associated with patient clinical characteristics. Gliomas exhibited a high abundance of macrophages, neutrophils, regulatory T cells, and the immune checkpoint PD‐L1, as well as high KLHDC8A expression. Cox regression analysis showed that KLHDC8A+CD68+ macrophages and KLHDC8A predicted unfavorable survival in patients with glioma. Finally, protein‐protein interaction network analysis showed that the KLHDC8A expression was associated with hypoxia and oxidative stress. Conclusions. KLHDC8A is a potential marker for the clinical diagnosis of glioma. The immune characteristics of macrophages play a crucial role in predicting patients with glioma, providing a new avenue for targeted glioma therapy.
- Open Access
- 31 August 2021
- Published by Springer Nature in Research Square
RNF208 is a Biomarker Associated with Immune Infiltration in Low-Grade Gliomas
Background: Gliomas that contain common tumors originating in the central nervous system include low-grade gliomas (LGGs) and high-grade gliomas (HGGs). RNF208 is a gene that has not been researched in LGGs. Methods: Our study appraised the function of RNF208 in LGGs using data from The Cancer Genome Atlas (TCGA) database. The RNF208 expression level was analyzed via the Oncomine and TCGA database. The association between RNF208 expression levels and the clinical survival outcomes was evaluated by using COX regression and Kaplan-Meier plotting analysis. CIBERSORT was applied to investigate the correlation between RNF208 expression levels and cancer immune infiltrating cells. To explore relevant biological processes, we carried out Gene Set Enrichment Analysis. A protein network interacting with RNF208 was also established using the STRING tool. Results: A group of data of LGGs patients based on the TCGA database revealed that high RNF208 expression level was relevant to a favorable prognosis. Besides, RNF208 expression that served as an independent factor was significantly correlated with WHO grade groups in univariate analysis. Furthermore, RNF208 expression was negatively correlated with the immune infiltration level of 22 species of immune infiltrating cells and immune checkpoints including PD1, PDL2, TIM3, and CTLA4. GSEA showed that 20 biological pathways were discriminatively enriched in the RNF208 low expression level. Conclusions: Our findings revealed that RNF208 would be regarded as a promising prognostic biomarker in LGGs.
- 31 August 2021
- Published by Springer Nature in Research Square
Open AccessRNF208 is a Biomarker Associated with Immune Infiltration in Low-Grade Gliomas
Background: Gliomas that contain common tumors originating in the central nervous system include low-grade gliomas (LGGs) and high-grade gliomas (HGGs). RNF208 is a gene that has not been researched in LGGs. Methods: Our study appraised the function of RNF208 in LGGs using data from The Cancer Genome Atlas (TCGA) database. The RNF208 expression level was analyzed via the Oncomine and TCGA database. The association between RNF208 expression levels and the clinical survival outcomes was evaluated by using COX regression and Kaplan-Meier plotting analysis. CIBERSORT was applied to investigate the correlation between RNF208 expression levels and cancer immune infiltrating cells. To explore relevant biological processes, we carried out Gene Set Enrichment Analysis. A protein network interacting with RNF208 was also established using the STRING tool. Results: A group of data of LGGs patients based on the TCGA database revealed that high RNF208 expression level was relevant to a favorable prognosis. Besides, RNF208 expression that served as an independent factor was significantly correlated with WHO grade groups in univariate analysis. Furthermore, RNF208 expression was negatively correlated with the immune infiltration level of 22 species of immune infiltrating cells and immune checkpoints including PD1, PDL2, TIM3, and CTLA4. GSEA showed that 20 biological pathways were discriminatively enriched in the RNF208 low expression level. Conclusions: Our findings revealed that RNF208 would be regarded as a promising prognostic biomarker in LGGs.